Stock Market News1 month NVO to Invest $1.2B in New Rare Disease Drugs Facility in Denmark Zacks
Novo Nordisk is set to invest $1.2 billion for a new facility in Odense, Denmark, to produce various product types for rare diseases, including haemophilia.
XNovo Nordisk is set to invest $1.2 billion for a new facility in Odense, Denmark, to produce various product types for rare diseases, including haemophilia.
X